Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Superconductor Corporation (AMSC) vs Nuwellis Inc (NUWE) Price & Performance

American Superconductor CorporationTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

American Superconductor Corporation vs Nuwellis Inc — how do they compare? American Superconductor Corporation trades at $32.48 (market cap $1.50B), while Nuwellis Inc trades at $1.48 (market cap $522.76K). The key difference: American Superconductor Corporation is far larger — about 2869.4× Nuwellis Inc's market cap, and American Superconductor Corporation is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

AMSCNUWE
Market Cap
$1.50B$522.76K
Sector
TechnologyTechnology
52-Week High
$66.68$220.50
52-Week Low
$25.95$1.42
Enterprise Value
$1.36B-$1.29M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Superconductor Corporation

AMSC trades at $32.77, down 0.41% with bearish technical signals including RSI overbought conditions and negative cash flow trends. The company reported strong revenue growth of 30% year-over-year in Q1 2026 to $94.1 million but faces margin pressure, with earnings missing estimates. Record orders above $130 million and a $400 million backlog provide visibility, though valuation metrics show mixed signals with a reasonable P/E of 10.06 but elevated EV/EBITDA of 63.13.

Outlook remains cautiously optimistic given strong order pipeline and exposure to energy infrastructure growth, particularly in grid solutions and data center markets. Key risks include margin compression from cost pressures and execution challenges in integrating recent growth. Analyst consensus leans bullish with 53% buy ratings, but investors should monitor Q3 earnings delivery and cash flow improvement for sustained upside.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Superconductor Corporation

AMSC provides energy technology solutions for smarter and cleaner power grids. It offers wind turbine electronic controls and advanced grid systems that enhance the reliability and efficiency of renewable energy networks.

Read more on AMSC

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE